This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Biocon Biologics Inc., a foreign-owned for-profit manufacturer of pharmaceutical products. The contract, valued up to $750,000, is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSC Code 65 IB.
The contract has a period of performance from March 1, 2024 to February 28, 2029 and does not utilize any set-asides. As an FSS contract, it is a multiple-award vehicle, allowing the VA and other federal agencies to place orders against the schedule. The contract aims to provide the VA and other eligible federal agencies access to a range of pharmaceutical and related medical products through an established procurement mechanism.
Generated 1/16/25, 9:03 AM